Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2019 Aug 22;18(7):1518–1527.e3. doi: 10.1016/j.cgh.2019.08.032

Table 3.

Predictors of CRN, Cox regression analysis

Univariable Multivariable
Events
n (%)
HR 95% CI p-value aHR 95% CI p-value
CRN, n (%) 46 (100)
Age - 1.03 1.01 – 1.05 0.003* 1.02 0.99 – 1.04 0.18
Male Sex 23 (50) 1.07 0.61 – 1.88 0.81 - - -
IND1 14 (30) 2.57 1.33 – 4.95 0.005* 3.25 1.50 – 7.05 0.003*
Prior IND 3 (7) 0.89 0.27 – 2.92 0.85 0.64 0.18 – 2.22 0.48
PSC 15 (33) 1.64 0.89 – 3.02 0.11 1.69 0.81 – 3.50 0.16
Mean Histologic Inflammation - 1.09 0.79 – 1.51 0.59 1.13 0.77 – 1.65 0.53
Disease duration - 1.02 1.00 – 1.05 0.07 1.02 0.99 – 1.06 0.21
Crohn’s Disease2 16 (35) 0.73 0.40 – 1.32 0.29 - - -
Number of adequate surveillance colonoscopies - 1.11 0.97 – 1.27 0.12 1.08 0.93 – 1.24 0.33
Extensive colitis 35 (76) 1.67 0.90 – 3.12 0.11 1.26 0.61 – 2.61 0.53
Family history of CRC 1 (2) 0.46 0.06 – 3.38 0.45 - - -
Exposure to biologicals 16 (35) 0.67 0.37 – 1.22 0.19 - - -
Exposure to immunomodulators 22 (48) 0.55 0.31 – 0.97 0.04 0.64 0.34 – 1.21 0.17
Exposure to 5-ASA 39 (85) 0.43 0.21 – 0.86 0.02 0.56 0.25 – 1.25 0.16

1) Entered as time-changing covariate 2) Reference category: UC/IBD-U 3) 7 patients were excluded due to missing values.

*

Significant at p<0.05.